| Ident. | Authors (with country if any) | Title |
|---|
| 000095 (2020-04-06) |
R. Djidjou-Demasse [France] ; Y. Michalakis ; M. Choisy ; M. T. Sofonea ; S. Alizon | Optimal COVID-19 epidemic control until vaccine deployment |
| 000188 (2018-12-17) |
Claire Rousset [France] | Coevolution of the HIV envelope glycoproteins and broadly neutralizing antibodies targeting the N332 glycan region |
| 000194 (2018-10-01) |
Emilie Bayon [France] ; Jessica Morlieras [France] ; Nathalie Dereuddre-Bosquet [France] ; Alexis Gonon [France] ; Leslie Gosse [France] ; Thomas Courant [France] ; Roger Le Grand [France] ; Patrice Marche [France] ; Fabrice Navarro [France] | Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates |
| 000353 (2015-10-05) |
Mélissanne De Wispelaere [France] ; Meret Ricklin [Suisse] ; Philippe Souque [France] ; Marie-Pascale Frenkiel [France] ; Sylvie Paulous [France] ; Obdulio Garcìa-Nicolàs [Suisse] ; Artur Summerfield [Suisse] ; Pierre Charneau [France] ; Philippe Desprès [France] | A Lentiviral Vector Expressing Japanese Encephalitis Virus-like Particles Elicits Broad Neutralizing Antibody Response in Pigs |
| 000381 (2015) |
Sophie Massin [France] ; Bruno Ventelou [France] ; Antoine Nebout-Javal [France] ; Pierre Verger [France] ; Céline Pulcini [France] | Cross-sectional survey: Risk-averse French general practitioners are more favorable toward influenza vaccination |
| 000448 (2014) |
Michael Pfleiderer [Allemagne] ; Jean-Hugues Trouvin [France] ; Daniel Brasseur [Belgique] ; Marta Gr Nstrom [Suède] ; Ragini Shivji [Royaume-Uni] ; Manuela Mura [Royaume-Uni] ; Marco Cavaleri [Royaume-Uni] | Summary of knowledge gaps related to quality and efficacy of current influenza vaccines |
| 000455 (2014) |
O. Launay [France] ; P. Y. Boelle [France] ; A. Krivine [France] ; D. Grenet [France] ; V. Boussaud [France] ; N. Remus [France] ; H. Corvol [France] ; F. Chedevergne [France] ; D. Hubert [France] ; I. Sermet-Gaudelus [France] | Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis |
| 000458 (2014) |
Nathalie Dhedin [France] ; Anne Krivine [France] ; Nicole Le Corre [France] ; Alain Mallet [France] ; Bruno Lioure [France] ; Jacques-Olivier Bay [France] ; Marie-Thérèse Rubio [France] ; Philippe Agape [Réunion] ; Anne Thiebaut [France] ; Jérôme Le Goff [France] ; Brigitte Autran [France] ; Patricia Ribaud [France] | Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients |
| 000531 (2013) |
J. Haensler [France] | Introduction aux nouveaux adjuvants vaccinaux et à leur rôle dans la vaccination antigrippale |
| 000537 (2013) |
Yves Dauvilliers [France] ; Isabelle Arnulf [France] ; Michel Lecendreux [France] ; Christelle Monaca Charley [France] ; Patricia Franco [France] ; Xavier Drouot [France] ; Marie-Pia D'Ortho [France] ; Sandrine Launois [France] ; Séverine Lignot [France] ; Patrice Bourgin [France] ; Béatrice Nogues [France] ; Marc Rey [France] ; Sophie Bayard [France] ; Sabine Scholz [France] ; Sophie Lavault [France] ; Pascale Tubert-Bitter [France] ; Cristel Saussier [France] ; Antoine Pariente [France] | Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France |
| 000538 (2013) |
Carlos A. Diazgranados [États-Unis] ; Andrew J. Dunning [États-Unis] ; Emilia Jordanov [États-Unis] ; Victoria Landolfi [États-Unis] ; Martine Denis [France] ; H. Keipp Talbot [États-Unis] | High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009-2010 season |
| 000540 (2013) |
Céline Pulcini [France] ; Sophie Massin [France] ; Odile Launay [France] ; Pierre Verger [France] | Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners: A 2010 survey |
| 000544 (2013) |
R. G. Pebody [Royaume-Uni] ; N. Andrews [Royaume-Uni] ; D. M. Fleming [Royaume-Uni] ; J. Mcmenamin [Royaume-Uni] ; S. Cottrell [Royaume-Uni] ; B. Smyth [Royaume-Uni] ; H. Durnall [Royaume-Uni] ; C. Robertson [Royaume-Uni, France] ; W. Carman [Royaume-Uni] ; J. Ellis [Royaume-Uni] ; P. Sebastian-Pillai [Royaume-Uni] ; M. Zambon [Royaume-Uni] ; C. Kearns [Royaume-Uni] ; C. Moore [Royaume-Uni] ; D. Rh. Thomas [Royaume-Uni] ; J. M. Watson [Royaume-Uni] | Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom |
| 000545 (2013) |
Barry D. Schoub [Afrique du Sud] ; Bradford D. Gessner [France] ; William Ampofo [Ghana] ; Adam L. Cohen [Afrique du Sud, États-Unis] ; Christoph A. Steffen [France] | Afriflu2-Second international workshop on influenza vaccination in the African continent-8 November 2012, Cape Town (South Africa) |
| 000608 (2012) |
Mélanie Moltenis [France] ; Marie-Blanche Valnet-Rabier [France] ; Joël Leroy [France] ; Jean-Pierre Kantelip [France] | Point sur les vaccinations à risque pendant la grossesse |
| 000617 (2012) |
Emmanuel Grimprel [France] | Nouveautés vaccinales en médecine humaine : Vaccins humains, vaccins vétérinaires, même combat |
| 000631 (2012) |
B. Rousseau [France] ; P. Loulergue [France] ; O. Mir [France] ; A. Krivine [France] ; S. Kotti [France] ; E. Viel [France] ; T. Simon [France] ; A. De Gramont [France] ; F. Goldwasser [France] ; O. Launay [France] ; C. Tournigand [France] | Immunogenicity and safety of the influenza A HINIv 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study |
| 000633 (2012) |
M. Valenciano [France] ; B. C. Ciancio [Suède] | I-MOVE: a European network to measure the effectiveness of influenza vaccines |
| 000635 (2012) |
I. Bonmarin [France] ; E. Belchior [France] ; Y. Le Strat [France] ; D. Levy-Bruhl [France] | First estimates of influenza vaccine effectiveness among severe influenza cases, France, 2011/12 |
| 000636 (2012) |
Geneviève Durrieu [France] ; Aurore Palmaro [France] ; Laure Pourcel [France] ; Céline Caillet [France] ; Angeline Faucher [France] ; Alexis Jacquet [France] ; Shéhérazade Ouaret [France] ; Marie Christine Perault-Pochat [France] ; Carmen Kreft-Jais [France] ; Anne Castot [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] | First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines: A Comparison of Reports Submitted by Patients and Healthcare Professionals |
| 000638 (2012) |
Colin R. Simpson [Royaume-Uni] ; Lewis D. Ritchie [Royaume-Uni] ; Chris Robertson [Royaume-Uni, France] ; Aziz Sheikh [Royaume-Uni] ; Jim Mcmenamin [Royaume-Uni] | Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study |
